The total number of records retrieved from this search are 2. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_5376	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5379	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504